Results 201 to 210 of about 36,146 (282)

Proteomic profiles in the aqueous following anti-vegf therapy in treatment naïve neovascular age-related macular degeneration. [PDF]

Clin Proteomics
Lynch AM, Drolet DW, Trinder KM, Gupta S, Westacott MJ, Janjic N, Palestine AG, Patnaik JL, Mathias MT, Mandava N, Wagner BD.   +10 more
europepmc   +1 more source

Correction: Infographic: 2-year efficacy, durability and safety of intravitreal faricimab with treat-and-extend dosing up to 16 weeks in neovascular age-related macular degeneration (pooled results from TENAYA and LUCERNE) [PDF]

Naomi Wijesingha, Aachal Kotecha, Philippe Margaron, Sobha Sivaprasad   +3 more
openalex   +1 more source

DERIVATION OF A SHORT FORM OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. [PDF]

Retina
Singerman L, Gugiu C, Tschosik E, Doll H, Singerman B, Gentile B.   +5 more
europepmc   +1 more source

EE190 From Clinical Trials to RWE: Defining Faricimab Value Drivers in Neovascular Age Related Macular Degeneration Through a Cost Utility Analysis [PDF]

Gabriele Ghetti, Camillo Porta, C Bührer, A Fasci   +3 more
openalex   +1 more source

Localising OCTA changes induced by the isometric hand-grip test to the superficial retina in neovascular age-related macular degeneration. [PDF]

Eye Vis (Lond)
Trinh M, Tee YG, Nam J, Chen S, Schiller G, Friedrich J, Ng D, Ly A, Hodge C, Nivison-Smith L.   +9 more
europepmc   +1 more source

INVOLUTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AFTER ENDOPHTHALMITIS

, 2019
Gregg T. Kokame, Nicolas A. Yannuzzi, Jessica G. Shantha, Maya Yamane, Nidhi Relhan, Jeffrey G. Gross, Edwin H. Ryan, Harry W. Flynn   +7 more
openalex   +2 more sources

The impact of swithching faricimab in the treatment of neovascular age-related macular degeneration: a real-world analysis. [PDF]

Graefes Arch Clin Exp Ophthalmol
Boscia G, Chauhan D, Corradetti G, O'Neill CP, Samarasinghe G, Lindenberg SM, Urrea A, Mauger S, Do G, Gupta M, Sadda SR.   +10 more
europepmc   +1 more source

Long-Term Changes in Submacular Choroidal Thickness after Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 14-Mo Follow-Up

, 2019
Sibel İnan, Zeki Baysal, Ümit Ubeyt İnan   +2 more
openalex   +2 more sources

Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United Kingdom. [PDF]

J Mark Access Health Policy
Lorenzi M, Ebohon S, Kissner J, Comiskey J, Paap M, Bouchet C, Garnham A, Wissinger E.   +7 more
europepmc   +1 more source

Antiangiogenic Drugs in Age Related Macular Degeneration: evidence based medicine and off-label use [PDF]

, 2011
Cachulo, ML, Faria de Abreu, JR, Figueira, J, Fonseca, P, Murta, JN, Pires, I, Silva, R   +6 more
core